Merck & Co Inc
(LTS:0QAH)
$
131.3
0 (0%)
Market Cap: 260.35 Bil
Enterprise Value: 283.89 Bil
PE Ratio: 21.58
PB Ratio: 5.86
GF Score: 81/100 
Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Oct 02, 2019 / 06:25PM GMT
Release Date Price:
$71.75
(-3.54%)
Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
Hi. Good afternoon. Thanks for attending the Merck session here. I have Mike Nally, the CMO of Merck. And we're going to a fireside chat. But before we begin, I wanted to see if you had any opening comments or remarks.
Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP
No. I mean it's just wonderful to be here. Thanks for the opportunity, and look forward to a good conversation.
Questions & Answers
Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
Okay. Great. So the first question I had for you is there's a lot of talk about leadership succession, and I'm curious, any comments from that front? And then the other thing that people ask me a lot is, is transformational M&A possible without a new CEO?
Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP
Well, I think your
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers